TP53 and endometrial carcinoma: In the study conducted by Opric D et al., examining 97 patients with endometrial carcinoma, 72 cases (74.2%) were diagnosed as the endometrioid type; the p53 expression was positive in 13.8% of the total number of cases, revealing that the frequency of p53 overexpression proportionally increases in conjunction with the histological grade [26].